Event Date/Time: Sep 24, 2010
Miniaturisation and automation of bioprocess development holds great promise in reducing the time and cost to market of new biopharmaceuticals. This meeting aims to highlight recent technologies used in high throughput bioprocess development, from clone selection through to analysis of final product and formulation. A series of expert speakers will describe the development and use of current miniaturisation technologies together with the technical and regulatory hurdles that must be overcome to facilitate wider industrial uptake."
This event has CPD accreditation and will have a discussion panel session.
On registration you will be able to submit your questions to the panel that will be asked by the chair on the day of the event
Meeting Chair - Professor Gary Lye, Professor of Biochemical Engineering, University College London